Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
The workshop was conducted as a part of the NITI–State workshop series
He is also inducted as a member of the management council and senior management personnel of the company
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Launch innovative vitamin sublingual sprays
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Subscribe To Our Newsletter & Stay Updated
